register

News & Trends - MedTech & Diagnostics

Ramsay Health Care to pilot short stay knee or hip arthroplasty

Health Industry Hub | December 9, 2020 |

MedTech News: Ramsay Australia will pilot a new short stay model of care. The ‘Short Stay Arthroplasty Pilot’, which has been adapted for Australia, aims to give patients and doctors the support and confidence needed to recover at home after a total knee or hip arthroplasty.

Eligible patients receive education, home based support and enrolment in a clinical pathway designed specifically for home based recovery within 23-47 hours of surgery.

Chairman of the Department of Orthopaedic Surgery at St George Private Hospital, Dr Samuel MacDessi said the pilot was being established to ensure it was a safe and efficient option for surgeons to use for their patients in the future.

“There is now evidence that overnight stay is at least as safe as a prolonged stay in hospital for appropriately selected patients and this pilot will provide surgeons with another option for managing their patients in the comfort of their own home,” Dr MacDessi said.

“We will only be doing this for patients who are suitable – they will need to reach all their discharge milestone and have someone at home who can help. The ability to access a Ramsay program offering in-home nursing and physiotherapy for rehabilitation will minimise the length of stay for patients who really want to be at home.”

Professor Richard de Steiger, Deputy Director of the Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) recently said “Over the past 12 years the length of stay for both hip and knee replacements has reduced from over 7 days to four. It is important that any further reduction in stay does not compromise the quality of joint replacement.”

Dr MacDessi said “There are some patients who want a prolonged stay in hospital but more and more, people are wanting to recover and rehabilitate at home. This pilot gives them access to nursing and physiotherapy services at home that are equal to what they would receive in the hospital environment,” he said.

The Short Stay Arthroplasty Pilot was designed with contribution from Ramsay’s global teams and input from orthopaedic surgeons, arthroplasty nurses and allied health.

The Short Stay Arthroplasty Pilot Project will be overseen by the Orthopaedic Advisory Panel and the National Clinical Governance Unit. A National Working Group – consisting of orthopaedic surgeons, anaesthetists, nursing, and physiotherapy representatives who are experienced in the development and implementation of enhanced recovery programs has been assembled to provide input into the development of the model of care and to be involved in the pilot phase of this initiative.


News & Trends - Pharmaceuticals

Is the government is gearing up to release the long-awaited response to The New Frontier report?

Government’s long-awaited response to The New Frontier report unveiled after two-year wait

Health Industry Hub | December 1, 2023 |

Pharma News: The Albanese Government has tabled its response to the House of Reps inquiry and The New Frontier report […]

More


News & Trends - Pharmaceuticals

Gilead welcomes HIV Taskforce report and celebrates the 'unsung heroes'

Gilead welcomes HIV Taskforce report and celebrates the ‘unsung heroes’

Health Industry Hub | December 1, 2023 |

Pharma News: On World AIDS Day, the National Association of People with HIV Australia (NAPWHA) and Gilead Sciences Australia have […]

More


News & Trends - Pharmaceuticals

AbbVie secures PBS listing of first therapy for Crohn's disease in seven years

AbbVie secures PBS listing of first therapy for Crohn’s disease in seven years

Health Industry Hub | December 1, 2023 |

Pharma News: AbbVie’s Rinvoq (upadacitinib), a once-daily tablet, has been officially listed on the Pharmaceutical Benefits Scheme (PBS) for adult […]

More


ESG

New report calls on policy integration of sustainability in medical device and pharmaceutical registrations and funding

New report calls on policy integration of sustainability in medical device and pharmaceutical registrations and funding

Health Industry Hub | November 30, 2023 |

ESG: Increasing pressures from diverse stakeholder groups, spanning policymakers, investors, customers, and employees, have elevated Environmental, Social, and Governance (ESG) […]

More


This content is copyright protected. Please subscribe to gain access.